346 related articles for article (PubMed ID: 16858075)
1. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies.
Hill PG; Forsyth JM; Rai B; Mayne S
Clin Chem; 2006 Sep; 52(9):1743-8. PubMed ID: 16858075
[TBL] [Abstract][Full Text] [Related]
2. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
[TBL] [Abstract][Full Text] [Related]
3. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
4. Ratio of urinary free immunoglobulin light chain kappa to lambda in the diagnosis of Bence Jones proteinuria.
Nakano T; Nagata A; Takahashi H
Clin Chem Lab Med; 2004 Apr; 42(4):429-34. PubMed ID: 15147154
[TBL] [Abstract][Full Text] [Related]
5. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio.
Levinson SS
Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809
[TBL] [Abstract][Full Text] [Related]
6. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain.
Levinson SS
Clin Chem Lab Med; 2011 Nov; 49(11):1801-4. PubMed ID: 21663562
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
Wood PB; McElroy YG; Stone MJ
Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
[TBL] [Abstract][Full Text] [Related]
8. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies: High False-Positive Rate.
Singh G
Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
Böer K; Deufel T
Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
[TBL] [Abstract][Full Text] [Related]
10. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
Smith J; Raines G; Schneider HG
Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
[TBL] [Abstract][Full Text] [Related]
11. A new concept for detection of Bence Jones proteinuria in patients with monoclonal gammopathy.
Hofmann W; Garbrecht M; Bradwell AR; Guder WG
Clin Lab; 2004; 50(3-4):181-5. PubMed ID: 15074473
[TBL] [Abstract][Full Text] [Related]
12. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies.
Katzmann JA; Snyder MR; Rajkumar SV; Kyle RA; Therneau TM; Benson JT; Dispenzieri A
Clin Chem; 2011 Dec; 57(12):1687-92. PubMed ID: 21980167
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic reference range of κ/λ free light chain ratio to screen for Bence Jones proteinuria is not significantly influenced by GFR.
Schmidt-Hieltjes Y; Elshof C; Roovers L; Ruinemans-Koerts J
Eur J Haematol; 2016 May; 96(5):527-31. PubMed ID: 26172558
[TBL] [Abstract][Full Text] [Related]
14. Biochemical profile of Bence-Jones type multiple myeloma.
Lyubimova NV; Timofeev YS; Abaev VM; Votyakova OM; Osmanov EA; Kushlinskii NE
Klin Lab Diagn; 2022 Oct; 67(10):570-574. PubMed ID: 36315171
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
16. Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies.
Holding S; Spradbery D; Hoole R; Wilmot R; Shields ML; Levoguer AM; Doré PC
Clin Chem Lab Med; 2011 Jan; 49(1):83-8. PubMed ID: 20961192
[TBL] [Abstract][Full Text] [Related]
17. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
Levinson SS
Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
[TBL] [Abstract][Full Text] [Related]
18. Serum free light chain specificity and sensitivity: a reality check.
Katzmann JA
Clin Chem; 2006 Sep; 52(9):1638-9. PubMed ID: 16940461
[No Abstract] [Full Text] [Related]
19. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
Abadie JM; Bankson DD
Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal].
Diop PA; Haudrechy D; Sylla-Niang M; Diedhiou A; Ngom L; Lopez-Sall P
Bull Soc Pathol Exot; 1998; 91(3):242-6. PubMed ID: 9773201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
